Briana Contreras is an editor at Managed Healthcare Executive, where she covers the clinical, business and policy developments that matter to payers and health plan leaders, with an additional focus in multiple clinical spaces. Her reporting spans from new cancer therapies and clinical trial data to drug affordability and biosimilars, pharmacy benefit management (PBM) and health plan operations, giving healthcare executives clear context on how new evidence can affect coverage and care decisions.
Experience:
Before joining MHE in 2019, Briana was a reporter at The Morning Journal in Lorain, Ohio, west of Cleveland, where she covered local government, community news and the issues affecting residents across Lorain and Erie counties. She reported on city council, downtown redevelopment, library and school projects, local business, nonprofits and breaking news in Elyria, Lorain and nearby communities.
Education:
Briana graduated from Cleveland State University with a B.A. in Journalism and Promotional Communication.
In this part one of three video series, CEO of VirtualHealth, Adam Sabloff, discusses the birth of the healthcare services institution, what it's offering to the industry and how value-based care, in particular, is transforming especially because of COVID-19.
In this week's episode of Tuning Into the C-Suite, MHE's Briana Contreras speaks with Adam Sabloff, CEO of VirtualHealth, about the current transformation of value-based care and what he thinks the future may look like for value-based care after COVID-19 and the presidential election.
Drugs block the formation of tiny blood vessels in the retina that are prone to breaking open, resulting in bleeds that can cause serious vision impairment and blindness, explains ADA chief scientific and medical officer, Robert Gabbay, in this conclusion of a four-part video series.
Less than half of Americans with diabetes get annual eye exams, says Robert Gabbay, M.D.,Ph.D., FACP, in this third of a four-part video series. Gabbay became chief scientific and medical officer for the American Diabetes Association this summer.
In this second of a four-part video series, ADA Chief Science and Medical Officer Robert Gabbay, MD, PhD, FACP, says data showing kidney benefits of SGLT2 inhibitors may indicate protection against retinopathy but research is needed.
The American Diabetes Association and other groups are mounting a public health campaign to encourage people with diabetes to get annual eye exams. ADA Chief Scientific and Medical Officer Robert Gabbay, MD, PhD, FACP, explains "leaky blood vessels" and diabetic retinopathy in this first of a four-part video series.
As the flu season approaches during the COVID-19 pandemic, Justin Zaghi of Heal says the flu shot is more important than ever this year for a few reasons.
In this week’s episode of Tuning Into the C-Suite podcast, MHE's Briana Contreras spoke with Sebastian Seiguer, CEO of emocha Mobile Health. The two talked about the key health challenges schools are facing as some are reopening across the country for the '20-'21 school year, how telehealth services like emocha are successfully using telehealth to open schools in a Return to Learn program, and paths forward for our nation’s largest school districts.
Brent James discusses the long-term consequences of COVID-19.
Brent James, M.D., M.Stat., the quality and patient safety expert, finds fault with singular focus on COVID-19. Watch James' interview in this part two of three video series.
Brent James, the quality and patient safety expert, sees excess mortality from lack of care for life-threatening conditions other than COVID-19. Watch James' interview in this part one of three video series.
This week on Tuning Into the C-Suite, Managed Healthcare Executive's Senior Editor, Peter Wehrwein, spoke with Georgetown's Sabrina Corlette, JD. The two discussed the possible motivations behind health insurer announcing premium credits and discounts in recent weeks and months after their profits (net income, for not-for-profits) swelled due to the drop-off in routine healthcare utilization.
Georgetown’s Sabrina Corlette says the 2021 rates were calculated before the recent announcements about COVID-19 premium relief in this part two of two video series.
Georgetown’s Sabrina Corlette explains some of the motivations behind the spate of premium credits and discounts from health insurers in this part one of two series.
In this week’s episode of Tuning Into the C-Suite, Briana Contreras of MHE chatted with CEO of Interim HealthCare, Jennifer Sheets. She and Jennifer discussed how COVID-19 has impacted the demand for home care, how hospitals can partner with the operation and how new pursuits in healthcare will affect home care in the future.
Senior Editor Peter Wehrwein speaks with Lou Ellen Horwitz, CEO of the Urgent Care Association, in this part two of two video series about centers that have not been paid yet for tests.
Senior Editor Peter Wehrwein speaks with Lou Ellen Horwitz, CEO of th eUrgent Care Association, about how urgent care centers struggled to personal protective equipment and access to testing.
This week on Tuning Into The C-Suite Briana Contreras spoke with Dr. Scott Hayworth, president and CEO of New York-based CareMount Medical. In this interview, the two discussed the importance of patients staying in contact with their doctors for the sake of reducing public health risks and to discuss ongoing care options with them.
In this part two of two series, Senior Editor Peter Wehrwein and Associate Editor Briana Contreras chat with Keely Macmillan, senior vice president of policy and solutions management at Archway Health. The trio discusses the Value in Health Care Act of 2020, which would make some important changes to the Medicare Shared Savings Programs ACOs, the largest CMS ACO program.
In this part one of two series, Senior Editor Peter Wehrwein and Associate Editor Briana Contreras chat with Keely Macmillan, senior vice president of policy and solutions management at Archway Health. The trio discusses the Value in Health Care Act of 2020, which would make some important changes to the Medicare Shared Savings Programs ACOs, the largest CMS ACO program.
Deloitte, a consulting firm, recently released new data on consumer behaviors towards healthcare and how those behaviors changed as a result of the COVID-19 pandemic in a survey.
A majority of executives believe technology has become an inseparable part of the human experience in a recent survey. However, a bit more than half of those execs said advancements in new technologies and scientific innovations are positioned to disrupt the industry.
In this week's episode, Briana Contreras spoke with Suzet McKinney, CEO of the Illinois Medical District and an Adjunct Instructor at Harvard University's T.H. Chan School of Public Health. The two discussed the role of social determinants when promoting health and health equity and most importantly why and how racism is a public health issue.
In this part two of two video series Adam Block discusses his recent article, “Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates.”
In this part one of two video series, Adam Block, a New York Medical College assistant professor, discusses his recent contributed article to Managed Healthcare Executive titled "Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates."
In this part two of two series, Carolyn Langer, M.D., Fallon Health's chief medical officer, talks about Collective Medical and the advantages of real-time notifications of member hospital admissions and discharges and emergency department visits.
This week on Tuning Into The C-Suite, Managed Healthcare Executive Senior Editor Peter Wehrwein speaks with Assistant Professor of Public Health at New York Medical College, Adam Block. The two discuss Block's recent article published in MHE, "Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates" and more.
In this part one of two series, Carolyn Langer, M.D., the chief medical officer, says the Massachusetts health plan mounted a big push on telehealth that includes in-person visit payment levels.
As several COVID-19 vaccine candidates are now in the late phase of clinical trials, MHE is sharing a few stories that have covered the infamous virus' vaccine development journey.
Briana Contreras speaks with Dan Knecht, Vice President of Clinical Product at CVS Health about telehealth, patient access, CVS minute clinics and Path to Better Health.
